APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Disease Prediction Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI Disease Prediction Software Market Analysis and Forecast 2026-2032

5 January 2026203 pages

Choose your research edition.

Industry ResearchAI Disease Prediction Software Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Disease Prediction Software Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal AI Disease Prediction Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Disease Prediction Software Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Disease Prediction Software Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global AI Disease Prediction Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Disease Prediction Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Disease Prediction Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Disease Prediction Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Disease Prediction Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Disease Prediction Software include IntelliGenes, IBM Watson Oncology, PathAI, Zebra Medical Vision, Siemens Healthineers, GitHub LifeAI, DeepView, Google DeepMind and Binariks, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Disease Prediction Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Disease Prediction Software, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Disease Prediction Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Disease Prediction Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Disease Prediction Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Disease Prediction Software revenue, projected growth trends, production technology, application and end-user industry.

AI Disease Prediction Software Segment by Company

IntelliGenes

IBM Watson Oncology

PathAI

Zebra Medical Vision

Siemens Healthineers

GitHub LifeAI

DeepView

Google DeepMind

Binariks

Paige.AI

Lunit INSIGHT

Arterys

Winterlight Labs

BrainScope

Livongo

Deep Genomics

IDx-DR

ChestEye

Viz.ai

AI Disease Prediction Software Segment by Type

Cloud-based

On-premises

AI Disease Prediction Software Segment by Application

Cancer

Cardiovascular Disease

Nervous System Disease

Chronic Disease and Metabolic Disease

Others

AI Disease Prediction Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Disease Prediction Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Disease Prediction Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Disease Prediction Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Disease Prediction Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Disease Prediction Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Disease Prediction Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Disease Prediction Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-based Major Player Table 3. On-premises Major Player Table 4. Global AI Disease Prediction Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cancer Major Player Table 6. Cardiovascular Disease Major Player Table 7. Nervous System Disease Major Player Table 8. Chronic Disease and Metabolic Disease Major Player Table 9. Others Major Player Table 10. AI Disease Prediction Software Industry Trends Table 11. AI Disease Prediction Software Industry Drivers Table 12. AI Disease Prediction Software Industry Opportunities and Challenges Table 13. AI Disease Prediction Software Industry Restraints Table 14. Global AI Disease Prediction Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global AI Disease Prediction Software Market Size by Region (2021-2026) & (US$ Million) Table 16. Global AI Disease Prediction Software Market Share by Region (2021-2026) Table 17. Global AI Disease Prediction Software Market Size by Region (2027-2032) & (US$ Million) Table 18. Global AI Disease Prediction Software Market Share by Region (2027-2032) Table 19. Global AI Disease Prediction Software Revenue by Players (US$ Million) & (2021-2026) Table 20. Global AI Disease Prediction Software Revenue Market Share by Players (2021-2026) Table 21. Global AI Disease Prediction Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global AI Disease Prediction Software Key Players Headquarters & Area Served Table 23. Global AI Disease Prediction Software Players, Product Type & Application Table 24. Global AI Disease Prediction Software Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global AI Disease Prediction Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global AI Disease Prediction Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global AI Disease Prediction Software Revenue by Type (2021-2026) & (US$ Million) Table 29. Global AI Disease Prediction Software Revenue by Type (2027-2032) & (US$ Million) Table 30. Global AI Disease Prediction Software Revenue Market Share by Type (2021-2026) Table 31. Global AI Disease Prediction Software Revenue Market Share by Type (2027-2032) Table 32. Global AI Disease Prediction Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global AI Disease Prediction Software Revenue by Application (2021-2026) & (US$ Million) Table 34. Global AI Disease Prediction Software Revenue by Application (2027-2032) & (US$ Million) Table 35. Global AI Disease Prediction Software Revenue Market Share by Application (2021-2026) Table 36. Global AI Disease Prediction Software Revenue Market Share by Application (2027-2032) Table 37. IntelliGenes Company Information Table 38. IntelliGenes Business Overview Table 39. IntelliGenes AI Disease Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. IntelliGenes AI Disease Prediction Software Product Portfolio Table 41. IntelliGenes Recent Development Table 42. IBM Watson Oncology Company Information Table 43. IBM Watson Oncology Business Overview Table 44. IBM Watson Oncology AI Disease Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. IBM Watson Oncology AI Disease Prediction Software Product Portfolio Table 46. IBM Watson Oncology Recent Development Table 47. PathAI Company Information Table 48. PathAI Business Overview Table 49. PathAI AI Disease Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. PathAI AI Disease Prediction Software Product Portfolio Table 51. PathAI Recent Development Table 52. Zebra Medical Vision Company Information Table 53. Zebra Medical Vision Business Overview Table 54. Zebra Medical Vision AI Disease Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Zebra Medical Vision AI Disease Prediction Software Product Portfolio Table 56. Zebra Medical Vision Recent Development Table 57. Siemens Healthineers Company Information Table 58. Siemens Healthineers Business Overview Table 59. Siemens Healthineers AI Disease Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Siemens Healthineers AI Disease Prediction Software Product Portfolio Table 61. Siemens Healthineers Recent Development Table 62. GitHub LifeAI Company Information Table 63. GitHub LifeAI Business Overview Table 64. GitHub LifeAI AI Disease Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. GitHub LifeAI AI Disease Prediction Software Product Portfolio Table 66. GitHub LifeAI Recent Development Table 67. DeepView Company Information Table 68. DeepView Business Overview Table 69. DeepView AI Disease Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. DeepView AI Disease Prediction Software Product Portfolio Table 71. DeepView Recent Development Table 72. Google DeepMind Company Information Table 73. Google DeepMind Business Overview Table 74. Google DeepMind AI Disease Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Google DeepMind AI Disease Prediction Software Product Portfolio Table 76. Google DeepMind Recent Development Table 77. Binariks Company Information Table 78. Binariks Business Overview Table 79. Binariks AI Disease Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Binariks AI Disease Prediction Software Product Portfolio Table 81. Binariks Recent Development Table 82. Paige.AI Company Information Table 83. Paige.AI Business Overview Table 84. Paige.AI AI Disease Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Paige.AI AI Disease Prediction Software Product Portfolio Table 86. Paige.AI Recent Development Table 87. Lunit INSIGHT Company Information Table 88. Lunit INSIGHT Business Overview Table 89. Lunit INSIGHT AI Disease Prediction Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Lunit INSIGHT AI Disease Prediction Software Product Portfolio Table 91. Lunit INSIGHT Recent Development Table 92. Arterys Company Information Table 93. Arterys Business Overview Table 94. Arterys AI Disease Prediction Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Arterys AI Disease Prediction Software Product Portfolio Table 96. Arterys Recent Development Table 97. Winterlight Labs Company Information Table 98. Winterlight Labs Business Overview Table 99. Winterlight Labs AI Disease Prediction Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Winterlight Labs AI Disease Prediction Software Product Portfolio Table 101. Winterlight Labs Recent Development Table 102. BrainScope Company Information Table 103. BrainScope Business Overview Table 104. BrainScope AI Disease Prediction Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. BrainScope AI Disease Prediction Software Product Portfolio Table 106. BrainScope Recent Development Table 107. Livongo Company Information Table 108. Livongo Business Overview Table 109. Livongo AI Disease Prediction Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Livongo AI Disease Prediction Software Product Portfolio Table 111. Livongo Recent Development Table 112. Deep Genomics Company Information Table 113. Deep Genomics Business Overview Table 114. Deep Genomics AI Disease Prediction Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Deep Genomics AI Disease Prediction Software Product Portfolio Table 116. Deep Genomics Recent Development Table 117. IDx-DR Company Information Table 118. IDx-DR Business Overview Table 119. IDx-DR AI Disease Prediction Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. IDx-DR AI Disease Prediction Software Product Portfolio Table 121. IDx-DR Recent Development Table 122. ChestEye Company Information Table 123. ChestEye Business Overview Table 124. ChestEye AI Disease Prediction Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. ChestEye AI Disease Prediction Software Product Portfolio Table 126. ChestEye Recent Development Table 127. Viz.ai Company Information Table 128. Viz.ai Business Overview Table 129. Viz.ai AI Disease Prediction Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Viz.ai AI Disease Prediction Software Product Portfolio Table 131. Viz.ai Recent Development Table 132. North America AI Disease Prediction Software Revenue by Type (2021-2026) & (US$ Million) Table 133. North America AI Disease Prediction Software Revenue by Type (2027-2032) & (US$ Million) Table 134. North America AI Disease Prediction Software Revenue by Application (2021-2026) & (US$ Million) Table 135. North America AI Disease Prediction Software Revenue by Application (2027-2032) & (US$ Million) Table 136. North America AI Disease Prediction Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. North America AI Disease Prediction Software Revenue by Country (2021-2026) & (US$ Million) Table 138. North America AI Disease Prediction Software Revenue by Country (US$ Million) & (2027-2032) Table 139. Europe AI Disease Prediction Software Revenue by Type (2021-2026) & (US$ Million) Table 140. Europe AI Disease Prediction Software Revenue by Type (2027-2032) & (US$ Million) Table 141. Europe AI Disease Prediction Software Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe AI Disease Prediction Software Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe AI Disease Prediction Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe AI Disease Prediction Software Revenue by Country (2021-2026) & (US$ Million) Table 145. Europe AI Disease Prediction Software Revenue by Country (US$ Million) & (2027-2032) Table 146. China AI Disease Prediction Software Revenue by Type (2021-2026) & (US$ Million) Table 147. China AI Disease Prediction Software Revenue by Type (2027-2032) & (US$ Million) Table 148. China AI Disease Prediction Software Revenue by Application (2021-2026) & (US$ Million) Table 149. China AI Disease Prediction Software Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia AI Disease Prediction Software Revenue by Type (2021-2026) & (US$ Million) Table 151. Asia AI Disease Prediction Software Revenue by Type (2027-2032) & (US$ Million) Table 152. Asia AI Disease Prediction Software Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia AI Disease Prediction Software Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia AI Disease Prediction Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Asia AI Disease Prediction Software Revenue by Region (US$ Million) & (2021-2026) Table 156. Asia AI Disease Prediction Software Revenue by Region (US$ Million) & (2027-2032) Table 157. SAMEA AI Disease Prediction Software Revenue by Type (2021-2026) & (US$ Million) Table 158. SAMEA AI Disease Prediction Software Revenue by Type (2027-2032) & (US$ Million) Table 159. SAMEA AI Disease Prediction Software Revenue by Application (2021-2026) & (US$ Million) Table 160. SAMEA AI Disease Prediction Software Revenue by Application (2027-2032) & (US$ Million) Table 161. SAMEA AI Disease Prediction Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. SAMEA AI Disease Prediction Software Revenue by Country (2021-2026) & (US$ Million) Table 163. SAMEA AI Disease Prediction Software Revenue by Country (US$ Million) & (2027-2032) Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. AI Disease Prediction Software Image Figure 2. Global AI Disease Prediction Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Disease Prediction Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-premises Image Figure 6. Global AI Disease Prediction Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global AI Disease Prediction Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cancer Image Figure 9. Cardiovascular Disease Image Figure 10. Nervous System Disease Image Figure 11. Chronic Disease and Metabolic Disease Image Figure 12. Others Image Figure 13. Global AI Disease Prediction Software Market Size (US$ Million) & (2021-2032) Figure 14. Global AI Disease Prediction Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global AI Disease Prediction Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global AI Disease Prediction Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global AI Disease Prediction Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global AI Disease Prediction Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global AI Disease Prediction Software Revenue Market Share by Type (2021-2032) Figure 21. Global AI Disease Prediction Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global AI Disease Prediction Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global AI Disease Prediction Software Revenue Market Share by Application (2021-2032) Figure 24. North America AI Disease Prediction Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America AI Disease Prediction Software Revenue Share by Type (2021-2032) Figure 26. North America AI Disease Prediction Software Revenue Share by Application (2021-2032) Figure 27. North America AI Disease Prediction Software Revenue Share by Country (2021-2032) Figure 28. United States AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe AI Disease Prediction Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe AI Disease Prediction Software Revenue Share by Type (2021-2032) Figure 33. Europe AI Disease Prediction Software Revenue Share by Application (2021-2032) Figure 34. Europe AI Disease Prediction Software Revenue Share by Country (2021-2032) Figure 35. Germany AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China AI Disease Prediction Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China AI Disease Prediction Software Revenue Share by Type (2021-2032) Figure 45. China AI Disease Prediction Software Revenue Share by Application (2021-2032) Figure 46. Asia AI Disease Prediction Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia AI Disease Prediction Software Revenue Share by Type (2021-2032) Figure 48. Asia AI Disease Prediction Software Revenue Share by Application (2021-2032) Figure 49. Asia AI Disease Prediction Software Revenue Share by Region (2021-2032) Figure 50. Japan AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA AI Disease Prediction Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA AI Disease Prediction Software Revenue Share by Type (2021-2032) Figure 58. SAMEA AI Disease Prediction Software Revenue Share by Application (2021-2032) Figure 59. SAMEA AI Disease Prediction Software Revenue Share by Country (2021-2032) Figure 60. Brazil AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt AI Disease Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premises
Applications
  • Cancer
  • Cardiovascular Disease
  • Nervous System Disease
  • Chronic Disease and Metabolic Disease
  • Others
Companies covered
  • IntelliGenes
  • IBM Watson Oncology
  • PathAI
  • Zebra Medical Vision
  • Siemens Healthineers
  • GitHub LifeAI
  • DeepView
  • Google DeepMind
  • Binariks
  • Paige.AI
  • Lunit INSIGHT
  • Arterys
  • Winterlight Labs
  • BrainScope
  • Livongo
  • Deep Genomics
  • IDx-DR
  • ChestEye
  • Viz.ai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Disease Prediction Software Market by Type
  3. 1.2.1 Global AI Disease Prediction Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-premises
  6. 1.3 AI Disease Prediction Software Market by Application
  7. 1.3.1 Global AI Disease Prediction Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cancer
  9. 1.3.3 Cardiovascular Disease
  10. 1.3.4 Nervous System Disease
  11. 1.3.5 Chronic Disease and Metabolic Disease
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 AI Disease Prediction Software Market Dynamics
  1. 2.1 AI Disease Prediction Software Industry Trends
  2. 2.2 AI Disease Prediction Software Industry Drivers
  3. 2.3 AI Disease Prediction Software Industry Opportunities and Challenges
  4. 2.4 AI Disease Prediction Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Disease Prediction Software Market Perspective (2021-2032)
  2. 3.2 Global AI Disease Prediction Software Growth Trends by Region
  3. 3.2.1 Global AI Disease Prediction Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Disease Prediction Software Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Disease Prediction Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Disease Prediction Software Revenue by Players
  2. 4.1.1 Global AI Disease Prediction Software Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Disease Prediction Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Disease Prediction Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Disease Prediction Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Disease Prediction Software Key Players Headquarters & Area Served
  7. 4.4 Global AI Disease Prediction Software Players, Product Type & Application
  8. 4.5 Global AI Disease Prediction Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Disease Prediction Software Market CR5 and HHI
  11. 4.6.3 2025 AI Disease Prediction Software Tier 1, Tier 2, and Tier 3
5 AI Disease Prediction Software Market Size by Type
  1. 5.1 Global AI Disease Prediction Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Disease Prediction Software Revenue by Type (2021-2032)
  3. 5.3 Global AI Disease Prediction Software Revenue Market Share by Type (2021-2032)
6 AI Disease Prediction Software Market Size by Application
  1. 6.1 Global AI Disease Prediction Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Disease Prediction Software Revenue by Application (2021-2032)
  3. 6.3 Global AI Disease Prediction Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 IntelliGenes
  2. 7.1.1 IntelliGenes Company Information
  3. 7.1.2 IntelliGenes Business Overview
  4. 7.1.3 IntelliGenes AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 IntelliGenes AI Disease Prediction Software Product Portfolio
  6. 7.1.5 IntelliGenes Recent Developments
  7. 7.2 IBM Watson Oncology
  8. 7.2.1 IBM Watson Oncology Company Information
  9. 7.2.2 IBM Watson Oncology Business Overview
  10. 7.2.3 IBM Watson Oncology AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 IBM Watson Oncology AI Disease Prediction Software Product Portfolio
  12. 7.2.5 IBM Watson Oncology Recent Developments
  13. 7.3 PathAI
  14. 7.3.1 PathAI Company Information
  15. 7.3.2 PathAI Business Overview
  16. 7.3.3 PathAI AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 PathAI AI Disease Prediction Software Product Portfolio
  18. 7.3.5 PathAI Recent Developments
  19. 7.4 Zebra Medical Vision
  20. 7.4.1 Zebra Medical Vision Company Information
  21. 7.4.2 Zebra Medical Vision Business Overview
  22. 7.4.3 Zebra Medical Vision AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Zebra Medical Vision AI Disease Prediction Software Product Portfolio
  24. 7.4.5 Zebra Medical Vision Recent Developments
  25. 7.5 Siemens Healthineers
  26. 7.5.1 Siemens Healthineers Company Information
  27. 7.5.2 Siemens Healthineers Business Overview
  28. 7.5.3 Siemens Healthineers AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Siemens Healthineers AI Disease Prediction Software Product Portfolio
  30. 7.5.5 Siemens Healthineers Recent Developments
  31. 7.6 GitHub LifeAI
  32. 7.6.1 GitHub LifeAI Company Information
  33. 7.6.2 GitHub LifeAI Business Overview
  34. 7.6.3 GitHub LifeAI AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GitHub LifeAI AI Disease Prediction Software Product Portfolio
  36. 7.6.5 GitHub LifeAI Recent Developments
  37. 7.7 DeepView
  38. 7.7.1 DeepView Company Information
  39. 7.7.2 DeepView Business Overview
  40. 7.7.3 DeepView AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 DeepView AI Disease Prediction Software Product Portfolio
  42. 7.7.5 DeepView Recent Developments
  43. 7.8 Google DeepMind
  44. 7.8.1 Google DeepMind Company Information
  45. 7.8.2 Google DeepMind Business Overview
  46. 7.8.3 Google DeepMind AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Google DeepMind AI Disease Prediction Software Product Portfolio
  48. 7.8.5 Google DeepMind Recent Developments
  49. 7.9 Binariks
  50. 7.9.1 Binariks Company Information
  51. 7.9.2 Binariks Business Overview
  52. 7.9.3 Binariks AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Binariks AI Disease Prediction Software Product Portfolio
  54. 7.9.5 Binariks Recent Developments
  55. 7.10 Paige.AI
  56. 7.10.1 Paige.AI Company Information
  57. 7.10.2 Paige.AI Business Overview
  58. 7.10.3 Paige.AI AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Paige.AI AI Disease Prediction Software Product Portfolio
  60. 7.10.5 Paige.AI Recent Developments
  61. 7.11 Lunit INSIGHT
  62. 7.11.1 Lunit INSIGHT Company Information
  63. 7.11.2 Lunit INSIGHT Business Overview
  64. 7.11.3 Lunit INSIGHT AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Lunit INSIGHT AI Disease Prediction Software Product Portfolio
  66. 7.11.5 Lunit INSIGHT Recent Developments
  67. 7.12 Arterys
  68. 7.12.1 Arterys Company Information
  69. 7.12.2 Arterys Business Overview
  70. 7.12.3 Arterys AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Arterys AI Disease Prediction Software Product Portfolio
  72. 7.12.5 Arterys Recent Developments
  73. 7.13 Winterlight Labs
  74. 7.13.1 Winterlight Labs Company Information
  75. 7.13.2 Winterlight Labs Business Overview
  76. 7.13.3 Winterlight Labs AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Winterlight Labs AI Disease Prediction Software Product Portfolio
  78. 7.13.5 Winterlight Labs Recent Developments
  79. 7.14 BrainScope
  80. 7.14.1 BrainScope Company Information
  81. 7.14.2 BrainScope Business Overview
  82. 7.14.3 BrainScope AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 BrainScope AI Disease Prediction Software Product Portfolio
  84. 7.14.5 BrainScope Recent Developments
  85. 7.15 Livongo
  86. 7.15.1 Livongo Company Information
  87. 7.15.2 Livongo Business Overview
  88. 7.15.3 Livongo AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Livongo AI Disease Prediction Software Product Portfolio
  90. 7.15.5 Livongo Recent Developments
  91. 7.16 Deep Genomics
  92. 7.16.1 Deep Genomics Company Information
  93. 7.16.2 Deep Genomics Business Overview
  94. 7.16.3 Deep Genomics AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Deep Genomics AI Disease Prediction Software Product Portfolio
  96. 7.16.5 Deep Genomics Recent Developments
  97. 7.17 IDx-DR
  98. 7.17.1 IDx-DR Company Information
  99. 7.17.2 IDx-DR Business Overview
  100. 7.17.3 IDx-DR AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  101. 7.17.4 IDx-DR AI Disease Prediction Software Product Portfolio
  102. 7.17.5 IDx-DR Recent Developments
  103. 7.18 ChestEye
  104. 7.18.1 ChestEye Company Information
  105. 7.18.2 ChestEye Business Overview
  106. 7.18.3 ChestEye AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  107. 7.18.4 ChestEye AI Disease Prediction Software Product Portfolio
  108. 7.18.5 ChestEye Recent Developments
  109. 7.19 Viz.ai
  110. 7.19.1 Viz.ai Company Information
  111. 7.19.2 Viz.ai Business Overview
  112. 7.19.3 Viz.ai AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Viz.ai AI Disease Prediction Software Product Portfolio
  114. 7.19.5 Viz.ai Recent Developments
8 North America
  1. 8.1 North America AI Disease Prediction Software Revenue (2021-2032)
  2. 8.2 North America AI Disease Prediction Software Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Disease Prediction Software Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Disease Prediction Software Revenue by Type (2027-2032)
  5. 8.3 North America AI Disease Prediction Software Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Disease Prediction Software Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Disease Prediction Software Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Disease Prediction Software Revenue by Application (2027-2032)
  9. 8.5 North America AI Disease Prediction Software Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Disease Prediction Software Revenue by Country
  11. 8.6.1 North America AI Disease Prediction Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Disease Prediction Software Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Disease Prediction Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Disease Prediction Software Revenue (2021-2032)
  2. 9.2 Europe AI Disease Prediction Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Disease Prediction Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Disease Prediction Software Revenue by Type (2027-2032)
  5. 9.3 Europe AI Disease Prediction Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Disease Prediction Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Disease Prediction Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Disease Prediction Software Revenue by Application (2027-2032)
  9. 9.5 Europe AI Disease Prediction Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Disease Prediction Software Revenue by Country
  11. 9.6.1 Europe AI Disease Prediction Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Disease Prediction Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Disease Prediction Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Disease Prediction Software Revenue (2021-2032)
  2. 10.2 China AI Disease Prediction Software Revenue by Type (2021-2032)
  3. 10.2.1 China AI Disease Prediction Software Revenue by Type (2021-2026)
  4. 10.2.2 China AI Disease Prediction Software Revenue by Type (2027-2032)
  5. 10.3 China AI Disease Prediction Software Revenue Share by Type (2021-2032)
  6. 10.4 China AI Disease Prediction Software Revenue by Application (2021-2032)
  7. 10.4.1 China AI Disease Prediction Software Revenue by Application (2021-2026)
  8. 10.4.2 China AI Disease Prediction Software Revenue by Application (2027-2032)
  9. 10.5 China AI Disease Prediction Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Disease Prediction Software Revenue (2021-2032)
  2. 11.2 Asia AI Disease Prediction Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Disease Prediction Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Disease Prediction Software Revenue by Type (2027-2032)
  5. 11.3 Asia AI Disease Prediction Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Disease Prediction Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Disease Prediction Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Disease Prediction Software Revenue by Application (2027-2032)
  9. 11.5 Asia AI Disease Prediction Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Disease Prediction Software Revenue by Country
  11. 11.6.1 Asia AI Disease Prediction Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Disease Prediction Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Disease Prediction Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Disease Prediction Software Revenue (2021-2032)
  2. 12.2 SAMEA AI Disease Prediction Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Disease Prediction Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Disease Prediction Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Disease Prediction Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Disease Prediction Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Disease Prediction Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Disease Prediction Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Disease Prediction Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Disease Prediction Software Revenue by Country
  11. 12.6.1 SAMEA AI Disease Prediction Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Disease Prediction Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Disease Prediction Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst